Skip to content
Clinical Trials – home

Futuremeds Targówek

Verified siteinfoFast reply

Poland ul. Św. Wincentego 93 lok.5,6,7,, 03-291 Warsaw, Poland

  • 6 trials recruiting
  • Arteriosclerosis · Atrial fibrillation · Obesity
  • Adults and children

About Specializations

Futuremeds Targówek in Warsaw, Poland specialises in clinical trials of conditions such as Arteriosclerosis, Atrial fibrillation, Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Futuremeds Targówek, researchers are assessing new anticoagulant strategies for atrial fibrillation to reduce stroke risk.

  • Evaluation of milvexian versus apixaban for cardioembolic event prevention
  • Investigation of composite outcomes of stroke and systemic embolism

The work supports safer treatment options for patients with heart rhythm disorders.

Skin and Connective Tissue Diseases

The site conducts long‑term safety studies of novel oral agents for moderate‑to‑severe plaque psoriasis, aiming to improve disease control.

  • Safety and tolerability of TAK‑279 in chronic skin disease
  • Evaluation of treatment effectiveness over extended periods

These trials help expand therapeutic choices for individuals living with persistent skin conditions.

Bacterial Infections and Mycoses

Investigators evaluate the immunogenicity of a 21‑valent pneumococcal conjugate vaccine in children, supporting better protection against pneumococcal infection.

  • Serotype‑specific IgG antibody response after vaccination
  • Opsonophagocytic activity across different pediatric age groups

Futuremeds Targówek contributes to public‑health vaccination strategies for infants, toddlers, children, and adolescents.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Św. Wincentego 93 lok.5,6,7,03-291 WarsawPoland
Recruiting now
6 trials
Conditions studied
23
Partner status
Verified site

More sites in WarsawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

21 clinical trials

Obesity+1

Recruiting

Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Diabetes mellitus+2

Recruiting

A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Hepatic fibrosis+2

Recruiting

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efruxifermin
  • Sponsor:Akero Therapeutics Inc.

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited

Osteoporosis postmenopausal

Not yet recruiting

Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Curateq Biologics Private Limited

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal polysaccharide serotype 1
  • Sponsor:Sanofi Vaccines US Inc.

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:GlaxoSmithKline Biologicals

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 678354 sodium salt
  • Sponsor:Ionis Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.